CHEMED CORP reported first quarter ended March 31, 2026 results: revenue $657.5 million, EPS GAAP Diluted Earnings-per-Share (EPS) of $4.84.
“quarter ended March 31, 2026, versus the comparable prior-year period. Results for Quarter Ended March 31, 2026 Consolidated operating results: · Revenue increased 1.6% to $657.5 million · GAAP Diluted Earnings-per-Share (EPS) of $4.84, a decrease of 0.4% · Adjusted Diluted EPS of $5.65, an increase of 0.4% VITAS segment operating results: · Net Patient Revenue”
Debt Financings
CHEMED CORP incurred revolving credit of $450 million with JPMorgan Chase Bank, N.A. at secured overnight financing rate (“SOFR”) plus an additional tiered rate maturing five years.
“On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”).”
Material Agreements
CHEMED CORP entered into Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $450 million (effective 2026-04-10).
“On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”).”
Earnings Releases
CHEMED CORP reported first quarter ended March 31, 2024 results: revenue $589.2 million, EPS $4.24.
“· Revenue increased 5.2% to $589.2 million · GAAP Diluted Earnings-per-Share (EPS) of $4.24, an increase of 18.4% · Adjusted Diluted EPS of $5.20, an increase of 21.5%”
M&A Transactions
CHEMED CORP completed an acquisition involving Covenant Health and Community Services, Inc., d/b/a Covenant Care for $85 million (closed 2024-04-17).
“VITAS Healthcare Corporation (“VITAS”), a wholly-owned indirect subsidiary of Chemed, completed its acquisition of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc., d/b/a Covenant Care, a Florida not for profit corporation (“Covenant”), for $85 million.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.